Erratum: Wire-interwoven nitinol stent outcome in the superficial femoral and proximal popliteal arteries: Twelve-month results of the SUPERB trial (Circulation: Cardiovascular Interventions (2015) 8 (e000937) DOI: 10.1161/CIRCINTERVENTIONS.113.000937);Wire-Interwoven Nitinol Stent Outcome in the Superficial Femoral and Proximal Popliteal Arteries: Twelve-Month Results of the SUPERB Trial

Circulation: Cardiovascular Interventions

Volumn 8, Issue 5, 2015, Pages

  Garcia, Lawrence ^a   Jaff, Michael R ^b   Metzger, Christopher ^c   Sedillo, Gino ^d   Pershad, Ashish ^e   Zidar, Frank ^f   Patlola, Raghotham ^g   Wilkins, Robert G ^h   Espinoza, Andrey ⁱ   Iskander, Ayman ^j   Khammar, George S ^k   Khatib, Yazan ^l   Beasley, Robert ^m   Makam, Satyaprakash ⁿ   Kovach, Richard ^o   Kamat, Suraj ^p   Leon, Luis R ^q   Eaves, William Britton ^r   Popma, Jeffrey J ^s   Mauri, Laura ^t   Donohoe, Dennis ^u   Base, Carol C ^u   Rosenfield, Kenneth ^b   more..

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c Wellmont Holston Valley Medical Center   (United States)

^d CardioVascular Solutions Institute   (United States)

^e BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

^f Austin Heart   (United States)

^g Cardiovascular Institute of the South   (United States)

^h Hattiesburg Clinic   (United States)

ⁱ PA   (United States)

^j St Joseph's Hospital Cardiology Assoc   (United States)

^k Division of Cardiology   (United States)

^l First Coast Cardiovascular Institute   (United States)

^m MOUNT SINAI MEDICAL CENTER   (United States)

ⁿ Cardiovascular Research of Northwest Indiana   (United States)

^o DEBORAH HEART AND LUNG CENTER   (United States)

^p Division of Cardiology Alice Heart Center   (United States)

^q Tucson Med Center   (United States)

^r Division of Cardiology Willis Knighton Bossier Medical Center   (United States)

^s BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^t BRIGHAM AND WOMEN S HOSPITAL   (United States)

^u IDEV Technologies Inc   (United States)

more..

Author keywords

biological mimetic; femoral artery; peripheral artery disease; stent

Indexed keywords

ADULT; AGED; ARTERY OCCLUSION; ARTICLE; CLINICAL ASSESSMENT; FEMALE; HUMAN; LIMB AMPUTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPLITEAL ARTERY; POPLITEAL ARTERY STENOSIS; PRIORITY JOURNAL; QUALITY OF LIFE; RESTENOSIS; REVASCULARIZATION; SELF EXPANDING NITINOL STENT; STENT FRACTURE; SUPERFICIAL FEMORAL ARTERY; VASCULAR PATENCY; WIRE INTERWOVEN NITINOL STENT; CLINICAL TRIAL; DEVICES; ENDOVASCULAR SURGERY; FEMORAL ARTERY; MIDDLE AGED; PATHOPHYSIOLOGY; PERIPHERAL ARTERIAL DISEASE; PROSPECTIVE STUDY; STENT; TREATMENT OUTCOME;

ALLOY; NITINOL;

AGED; ALLOYS; ENDOVASCULAR PROCEDURES; FEMALE; FEMORAL ARTERY; HUMANS; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; PROSPECTIVE STUDIES; QUALITY OF LIFE; STENTS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 84937574854     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/HCV.0000000000000014     Document Type: Erratum

References (31)

1. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME, McDermott MM, Hiatt WR. The PARTNERS program: a national survey of peripheral arterial disease detection, awareness, and treatment. JAMA. 2001;286:1317-1324.
2. Centers for Disease Control and Prevention. Division of Heart Diseases and Stroke Prevention. Peripheral artery disease (PAD) fact sheet. http://www.cdc.gov/dhdsp/data-statistics/fact-sheets/fs-pad.htm. Accessed July 22, 2013.
3. American Heart Association. Heart Disease and Stroke Statistics - 2013 Update. http://circ.ahajournals.org/content/127/1/e6.full.pdf+html. Accessed July 22, 2013.
4. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45(suppl S):S5-S67. doi: 10.1016/j.jvs.2006.12.037.
5. Laird JR. Limitations of percutaneous transluminal angioplasty and stenting for the treatment of disease of the superficial femoral and popliteal arteries. J Endovasc Ther. 2006;13:II30-II40.
6. Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Tielbeek A, Anderson J, Wiesinger B, Tepe G, Lansky A, Mudde C, Tielemans H, Bérégi JP. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol. 2005;16:331-338. doi: 10.1097/01.RVI.0000151260.74519.CA.
7. Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Oliva V, Tielbeek A, Anderson J, Wiesinger B, Tepe G, Lansky A, Jaff MR, Mudde C, Tielemans H, Beregi JP. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther. 2006;13:701-710. doi: 10.1583/05-1704.1.
8. Krankenberg H, Schlüter M, Steinkamp HJ, Bürgelin K, Scheinert D, Schulte KL, Minar E, Peeters P, Bosiers M, Tepe G, Reimers B, Mahler F, Tübler T, Zeller T. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation. 2007;116:285-292. doi: 10.1161/CIRCULATIONAHA.107.689141.
9. Zeller T, Tiefenbacher C, Steinkamp HJ, Langhoff R, Wittenberg G, Schlüter M, Buergelin K, Rastan A, Krumsdorf U, Sixt S, Schulte CL, Tübler T, Krankenberg H. Nitinol stent implantation in TASC A and B superficial femoral artery lesions: the Femoral Artery Conformexx Trial (FACT). J Endovasc Ther. 2008;15:390-398. doi: 10.1583/08-2461.1.
10. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, Schlager O, Cejna M, Lammer J, Minar E. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006;354:1879-1888. doi: 10.1056/NEJMoa051303.
11. Dake MD, Scheinert D, Tepe G, Tessarek J, Fanelli F, Bosiers M, Ruhlmann C, Kavteladze Z, Lottes AE, Ragheb AO, Zeller T; Zilver PTX Single-Arm Study Investigators. Nitinol stents with polymer-free paclitaxel coating for lesions in the superficial femoral and popliteal arteries above the knee: twelve-month safety and effectiveness results from the Zilver PTX single-arm clinical study. J Endovasc Ther. 2011;18:613-623. doi: 10.1583/11-3560.1.
12. Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, Zeller T, Roubin GS, Burket MW, Khatib Y, Snyder SA, Ragheb AO, White JK, Machan LS; Zilver PTX Investigators. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv. 2011;4:495-504. doi: 10.1161/ CIRCINTERVENTIONS.111.962324.
13. Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, Dave R, Ansel G, Lansky A, Cristea E, Collins TJ, Goldstein J, Jaff MR; RESILIENT Investigators. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv. 2010;3:267-276. doi: 10.1161/ CIRCINTERVENTIONS.109.903468.
14. Bosiers M, Torsello G, Gissler HM, Ruef J, Müller-Hülsbeck S, Jahnke T, Peeters P, Daenens K, Lammer J, Schroë H, Mathias K, Koppensteiner R, Vermassen F, Scheinert D. Nitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I study. J Endovasc Ther. 2009;16:261-269. doi: 10.1583/08-2676.1.
15. Sabeti S, Mlekusch W, Amighi J, Minar E, Schillinger M. Primary patency of long-segment self-expanding nitinol stents in the femoropopliteal arteries. J Endovasc Ther. 2005;12:6-12. doi: 10.1583/04-1359.1.
16. Patrick J. Geraghty PJ, Mewissen MW, MD, Jaff MR, Ansel GM; for the VIBRANT Investigators. Three-year results of the VIBRANT trial of VIABAHN endoprosthesis vs bare nitinol stent implantation for complex superficial femoral artery occlusive disease. J Vasc Surg. 2013; 58:386-395.
17. Allie D, Herbert C, Walker C. Nitinol stent fractures in the SFA. Endovasc Today. 2004;6:22-34.
18. Berry JL, Manoach E, Mekkaoui C, Rolland PH, Moore JE Jr, Rachev A. Hemodynamics and wall mechanics of a compliance matching stent: in vitro and in vivo analysis. J Vasc Interv Radiol. 2002;13:97-105.
19. Rachev A, Manoach E, Berry J, Moore JE Jr. A model of stress-induced geometrical remodeling of vessel segments adjacent to stents and artery/ graft anastomoses. J Theor Biol. 2000;206:429-443. doi: 10.1006/ jtbi.2000.2143.
20. Abè H, Hayashi K, Sato M. Data Book on Mechanical Properties of Living Cells, Tissues, and Organs. New York, NY: Springer; 1996.
21. Rocha-Singh KJ, Jaff MR, Crabtree TR, Bloch DA, Ansel G; VIVA Physicians, Inc. Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease. Catheter Cardiovasc Interv. 2007;69:910-919. doi: 10.1002/ccd.21104.
22. Spertus J, Jones P, Poler S, Rocha-Singh K. The peripheral artery questionnaire: a new disease-specific health status measure for patients with peripheral arterial disease. Am Heart J. 2004;147:301-308. doi: 10.1016/j. ahj.2003.08.001.
23. Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220-233.
24. Ware J, Kosinski M, Bjorner JB, Turner-Bowker DM, Gandek B, Maruish ME. Determining Important Differences in Scores. User's Manual for the SF-36v2 Health Survey. Lincoln, RI: QualityMetric Incorporated; 2007.
25. Wyrwich KW, Spertus JA, Kroenke K, Tierney WM, Babu AN, Wolinsky FD; Heart Disease Expert Panel. Clinically important differences in health status for patients with heart disease: an expert consensus panel report. Am Heart J. 2004;147:615-622. doi: 10.1016/j.ahj.2003.10.039.
26. Safley DM, House JA, Laster SB, Daniel WC, Spertus JA, Marso SP. Quantifying improvement in symptoms, functioning, and quality of life after peripheral endovascular revascularization. Circulation. 2007;115:569-575. doi: 10.1161/CIRCULATIONAHA.106.643346.
27. Scheinert D, Grummt L, Piorkowski M, Sax J, Scheinert S, Ulrich M, Werner M, Bausback Y, Braunlich S, Schmidt A. A novel self-expanding interwoven nitinol stent for complex femoropopliteal lesions: 24-month results of the SUPERA SFA registry. J Endovasc Ther. 2011;18:745-752. doi: 10.1583/11-3500.1.
28. Scheinert D, Werner M, Scheinert S, Paetzold A, Banning-Eichenseer U, Piorkowski M, Ulrich M, Bausback Y, Bräunlich S, Schmidt A. Treatment of complex atherosclerotic popliteal artery disease with a new self-expanding interwoven nitinol stent: 12-month results of the Leipzig SUPERA popliteal artery stent registry. JACC Cardiovasc Interv. 2013;6:65-71. doi: 10.1016/j.jcin.2012.09.011.
29. Jaff MR. Paper presented at: VIVA 2012: Vascular InterVentional Advances (VIVA) Conference, October 10, 2012, Las Vegas, NV.
30. Matsumura JS, Yamanouchi D, Goldstein JA, Pollock CW, Bosiers M, Schultz GA, Scheinert D, Rocha-Singh KJ. The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II). J Vasc Surg. 2013;58:73-83. e1. doi: 10.1016/j.jvs.2012.12.066.
31. Coolong A, Baim DS, Kuntz RE, O'Malley AJ, Marulkar S, Cutlip DE, Popma JJ, Mauri L. Saphenous vein graft stenting and major adverse cardiac events: a predictive model derived from a pooled analysis of 3958 patients. Circulation. 2008;117:790-797. doi: 10.1161/ CIRCULATIONAHA.106.651232.